Home/Filings/8-K/0001213900-26-005254
8-K//Current report

Western Uranium & Vanadium Corp. 8-K

Accession 0001213900-26-005254

$WSTRFCIK 0001621906operating

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 5:21 PM ET

Size

216.5 KB

Accession

0001213900-26-005254

Research Summary

AI-generated summary of this filing

Updated

Western Uranium & Vanadium Grants 1.35M Stock Options to Officers and Staff

What Happened
Western Uranium & Vanadium Corp. announced (8-K filed Jan 16, 2026) that it granted a total of 1,350,000 stock options under its Incentive Stock Option Plan to various officers, directors and employees. The options were granted on January 15, 2026, carry an exercise price of CA$0.90, and have a five‑year exercise term beginning on each option’s vesting date. Western issued a news release about the grants on January 16, 2026.

Key Details

  • Total options granted: 1,350,000 options to officers, directors and employees.
  • Grant date: January 15, 2026; news release issued January 16, 2026.
  • Exercise price: CA$0.90 per share (set based on closing prices on the two trading days before the grant and recent private placement pricing).
  • Vesting schedule: equal thirds vest on Jan 31, 2026; July 31, 2026; and Jan 31, 2027.
  • Term: each option is exercisable for five years from its vesting date.
  • If all options are exercised, the company would receive proceeds of CA$1,215,000 (1,350,000 × CA$0.90) and up to 1,350,000 new shares could be issued.

Why It Matters
This grant is a compensation and retention action for management and employees; it can motivate staff alignment with company performance. For investors, the main effects to watch are potential dilution (up to 1,350,000 additional shares if exercised) and possible cash inflow to the company if holders exercise their options (up to CA$1.215 million). The exercise price was set using recent market and private placement pricing, which investors can compare to current share price to assess likelihood of exercise.